Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs PTC✓SelectedUSD · PTCGSK vs PTC performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs PTC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
PTC return
+64.3%
Excess return
-17.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioPTCExcessAlpha
1D-0.1%+0.2%-0.3%-0.1%
7D-1.3%+0.3%-1.6%-1.3%
30D+2.7%+1.8%+1.0%+2.6%
3M+2.7%+31.1%-28.4%+0.5%
6M+3.3%+38.4%-35.1%+0.4%
YTD+6.5%+12.7%-6.3%+5.6%
1Y+10.7%+9.3%+1.3%+10.1%
3Y+64.4%+28.5%+35.9%+56.9%
5Y+46.7%+59.9%-13.2%+32.5%
All+46.7%+64.3%-17.6%+32.5%

Cumulative growth

Daily Returns

Daily percentage return beside PTC.

Daily Out/Under-Performance

Portfolio return minus PTC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × PTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded PTC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling